FDA Approved: SOGROYA — Original Application (Novo Nordisk)

View source ↗

Summary

The FDA approved Sogroya (somapacitan) in an original application for adults with growth hormone deficiency, introducing a once-weekly long-acting growth hormon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Sogroya (somapacitan)

Snippet

ORIG AP for SOGROYA (SOMAPACITAN-BECO)